Muscle pain induced by hypertonic saline in the knee extensors decreases single-limb isometric time to task failure.


Journal

European journal of applied physiology
ISSN: 1439-6327
Titre abrégé: Eur J Appl Physiol
Pays: Germany
ID NLM: 100954790

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 15 01 2020
accepted: 19 06 2020
pubmed: 3 7 2020
medline: 9 6 2021
entrez: 3 7 2020
Statut: ppublish

Résumé

Increased nociceptive activity and the experience of exercise-induced pain (EIP) may contribute to fatigue during endurance exercise. To investigate this, a pain model that produces pain similar to EIP and decouples its relationship to exercise intensity is required. This study (1) compared the quality of pain caused by a hypertonic saline injection into the vastus lateralis in resting and exercise conditions, and (2) investigated whether this pain contributes to changes in time to task failure. On separate days, 18 participants completed a time to task failure at 20% maximal voluntary torque (MVT), a resting hypertonic saline intramuscular injection, and in a further three visits a time to task failure at 10% MVT following injection of isotonic saline, hypertonic saline or a control (no injection). In a subset of eligible participants (n = 12), the hypertonic saline combined with 10% MVT produced a qualitative experience of pain (assessed by the McGill Pain Questionnaire) that felt similar to EIP. 10% MVT with hypertonic saline significantly elevated pain intensity in the first 20% of the time to task failure and caused a significantly (P < 0.05) shorter time to task failure (448 ± 240 s) compared with the isotonic saline (605 ± 285 s) and control (514 ± 197 s) conditions. These findings demonstrate that hypertonic saline increases the intensity of pain during exercise, which results in a faster occurrence of exercise-induced fatigue. These results provide important evidence supporting pain as a limiting factor in endurance performance.

Identifiants

pubmed: 32613451
doi: 10.1007/s00421-020-04425-2
pii: 10.1007/s00421-020-04425-2
pmc: PMC7419372
doi:

Substances chimiques

Saline Solution, Hypertonic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2047-2058

Références

Exp Physiol. 2014 Feb;99(2):368-80
pubmed: 24142455
Basic Clin Pharmacol Toxicol. 2004 Sep;95(3):97-111
pubmed: 15447733
J Pain. 2014 Mar;15(3):271.e1-7
pubmed: 24275316
Pain. 1997 Jan;69(1-2):137-43
pubmed: 9060024
J Pain. 2007 Jul;8(7):583-7
pubmed: 17462960
Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R245-56
pubmed: 16484434
Pain. 2011 Mar;152(3 Suppl):S90-8
pubmed: 21087823
Exerc Sport Sci Rev. 1999;27:119-66
pubmed: 10791016
Front Physiol. 2013 May 13;4:104
pubmed: 23717284
Eur J Appl Physiol. 2017 Mar;117(3):483-492
pubmed: 28160085
J Physiol. 2009 Jan 15;587(1):271-83
pubmed: 19015193
Med Sci Sports Exerc. 1980;12(5):345-51
pubmed: 7453512
Med Sci Sports Exerc. 1997 Aug;29(8):999-1012
pubmed: 9268956
J Appl Physiol (1985). 2019 Nov 1;127(5):1257-1266
pubmed: 31513446
J Biomech. 2006;39(11):2005-13
pubmed: 16129444
J Physiol. 2011 Nov 1;589(Pt 21):5299-309
pubmed: 21878520
Eur J Appl Physiol. 2004 May;91(5-6):604-14
pubmed: 14685868
Can J Physiol Pharmacol. 1991 May;69(5):683-94
pubmed: 1863921
Muscle Nerve. 1999 Nov;22(11):1564-70
pubmed: 10514235
J Physiol. 2020 Jan;598(2):285-302
pubmed: 31826296
Pharmacol Rev. 2012 Jul;64(3):722-79
pubmed: 22722894
J Appl Physiol (1985). 2011 Sep;111(3):743-50
pubmed: 21737829
Am J Physiol Regul Integr Comp Physiol. 2015 Jun 15;308(12):R1008-20
pubmed: 25855308
Muscle Nerve. 1984 Nov-Dec;7(9):691-9
pubmed: 6100456
Muscle Nerve. 2002 Nov;26(5):708-12
pubmed: 12402294
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
J Physiol. 2008 Jan 1;586(1):161-73
pubmed: 17962334
Eur J Pain. 2013 Jan;17(1):124-31
pubmed: 22715044
J Pain. 2011 Apr;12(4):460-7
pubmed: 21146464
Med Sci Sports Exerc. 2011 Nov;43(11):2039-45
pubmed: 21502884
Electroencephalogr Clin Neurophysiol. 1997 Apr;105(2):156-64
pubmed: 9152211
J Physiol. 2013 Jul 15;591(14):3591-604
pubmed: 23652589
Open Access J Sports Med. 2014 Sep 05;5:209-14
pubmed: 25228823
Pain. 1993 Sep;54(3):241-89
pubmed: 8233542
Pain. 1975 Sep;1(3):277-99
pubmed: 1235985
Auton Neurosci. 2015 Mar;188:19-23
pubmed: 25458423
Sports Med. 2017 Nov;47(11):2375-2393
pubmed: 28283993
J Physiol. 2018 Oct;596(19):4789-4801
pubmed: 30095164
J Biomech. 1997 Jun;30(6):595-602
pubmed: 9165393
Eur J Pain. 2010 Oct;14(9):932-8
pubmed: 20378379
Eur J Appl Physiol. 2000 Jan;81(1-2):2-10
pubmed: 10552260
Sports Med. 2008;38(3):239-52
pubmed: 18278984
Pain. 1997 Jan;69(1-2):111-7
pubmed: 9060020

Auteurs

Samuel A Smith (SA)

Endurance Research Group, School of Sport and Exercise Sciences, University of Kent, Chatham, Kent, ME4 4AG, UK.

Dominic Micklewright (D)

School of Sport, Rehabilitation and Exercise Sciences, University of Essex, Wivenhoe Park, Colchester, UK.

Samantha L Winter (SL)

Endurance Research Group, School of Sport and Exercise Sciences, University of Kent, Chatham, Kent, ME4 4AG, UK.

Alexis R Mauger (AR)

Endurance Research Group, School of Sport and Exercise Sciences, University of Kent, Chatham, Kent, ME4 4AG, UK. lex.mauger@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH